Biologicals and biosimilars in IBD — the road to personalized treatment

被引：0
|
作者：
Krisztina B. Gecse
Péter L. Lakatos
机构：
[1] Semmelweis University,First Department of Medicine
来源：
Nature Reviews Gastroenterology & Hepatology | 2017年 / 14卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In 2016, personalized medicine for IBD has been evolving. Increasing comfort with biosimilar infliximab was achieved with 'real-life' data. Drugs with alternative modes of action confirmed substantial benefit, even in patients failing anti-TNF agents. Adipose-derived mesenchymal stem cells yielded a new treatment option for perianal fistulas.
引用
收藏
页码：74 / 76
页数：2
相关论文
共 50 条
  • [1] Biologicals and biosimilars in IBD-the road to personalized treatment
    Gecse, Krisztina B.
    Lakatos, Peter L.
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2017, 14 (02) : 74 - 76
  • [2] BIOLOGICALS AND BIOSIMILARS: AN OVERVIEW
    Shankar, K. Ravi
    Chowdary, K. P. R.
    [J]. INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (03): : 2015 - 2022
  • [3] Biologicals and biosimilars: Is similar the same?
    Declerck, P. J.
    [J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 : S427 - S427
  • [4] Biosimilars in IBD
    Brierley, Rob
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (01): : 14 - 14
  • [5] Biologicals and biosimilars: safety issues in Europe
    Constantino Portela, Maria da Conceicao
    Sinogas, Carlos
    de Almeidad, Fernando Albuquerque
    Baptista-Leite, Ricardo
    Castro-Caldas, Alexandre
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (07) : 871 - 877
  • [6] ADRs for selected biologicals and biosimilars comparable
    [J]. Reactions Weekly, 2017, 1674 (1) : 1 - 1
  • [7] Biologicals and Biosimilars in Hematology: The Case of Rituximab
    Vulto, Arnold G.
    [J]. HEMASPHERE, 2019, 3 (06):
  • [8] Increased monitoring of biologicals and biosimilars in Denmark
    [J]. Reactions Weekly, 2016, 1594 (1) : 2 - 2
  • [9] Forum discusses biosimilars, better biologicals
    Thompson, Cheryl A.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (23) : 2210 - 2210
  • [10] Pharmacovigilance on biologicals and biosimilars: a Danish perspective
    Lunddahl, Benedicte
    [J]. GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 2016, 5 (03): : 123 - 124
12345